Breast Cancer Research

Breast Cancer Research

Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.

Clinical Trials

Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: THE ABC Trial
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer
Personalized Exercise Oncology (PEXO) - Study
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology
Research into breast cancer at Penn State Cancer Institute is conducted by a dedicated breast cancer team. See current clinical trials and members of that team here.
Nurse AMIE: A Tablet Based Supportive Care Platform in Metastatic Breast Cancer (AMIE = Addressing Metastatic Individuals Everyday)
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: THE ABC Trial
Impact of Prehabilitation in Oncology Via Exercise - Breast Cancer
Communication Preferences Related to Over Screening for Cancer Among Older Adults
Randomized Study of Patient Navigation for Women Diagnosed with Dense Breast Tissue on a Breast Cancer Screening Mammography
A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negartive Early Breast Cancer
Personalized Exercise Oncology (PEXO) - Study
Clinicopathologic Study of Breast Cancer
Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)